1. Home
  2. LEU vs AMRX Comparison

LEU vs AMRX Comparison

Compare LEU & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Centrus Energy Corp.

LEU

Centrus Energy Corp.

HOLD

Current Price

$196.76

Market Cap

4.2B

Sector

Industrials

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$14.80

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEU
AMRX
Founded
1998
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.0B
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
LEU
AMRX
Price
$196.76
$14.80
Analyst Decision
Buy
Buy
Analyst Count
13
4
Target Price
$232.92
$13.25
AVG Volume (30 Days)
1.5M
3.8M
Earning Date
02-10-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.90
0.02
Revenue
$448,700,000.00
$2,934,959,000.00
Revenue This Year
$8.58
$9.99
Revenue Next Year
$3.99
$6.48
P/E Ratio
$51.07
$789.64
Revenue Growth
1.52
9.50
52 Week Low
$49.40
$6.69
52 Week High
$464.25
$15.00

Technical Indicators

Market Signals
Indicator
LEU
AMRX
Relative Strength Index (RSI) 32.89 67.23
Support Level $230.51 $14.55
Resistance Level $276.89 $14.99
Average True Range (ATR) 29.50 0.48
MACD -11.80 0.01
Stochastic Oscillator 1.82 78.84

Price Performance

Historical Comparison
LEU
AMRX

About LEU Centrus Energy Corp.

Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: